How do I buy Tyra Biosciences, Inc. Common Stock (TYRA) stock?

Buying Tyra Biosciences, Inc. Common Stock (TYRA) stock is now easy and instant through the Gotrade app. Download the Gotrade app from the App Store or Google Play. Create an account and complete KYC. Make a deposit. Search for the code "TYRA", then tap "Trade". Tap the "Buy" button. Enter the amount you want to buy. You have two options: Buy TYRA by number of shares. Buy fractional shares in dollars, starting from $1. Swipe up to confirm your order, and you're done!

What is the minimum investment for TYRA on Gotrade?

On Gotrade, you don't have to buy a full lot. With fractional shares, you can start investing in Tyra Biosciences, Inc. Common Stock from just $1. A small budget shouldn't stop you from building a US stock portfolio.

Does Tyra Biosciences, Inc. Common Stock (TYRA) pay dividends?

At the moment, Tyra Biosciences, Inc. Common Stock (TYRA) does not pay dividends because it focuses on reinvesting profits for company growth (a growth stock). However, you can still potentially earn profit from share price increases (capital gains). Track TYRA's performance via the price chart in the Gotrade app.

Is buying TYRA on Gotrade safe and legal?

Gotrade is the trading name of Gotrade Securities Inc., which is registered with and supervised by the Labuan Financial Services Authority (LFSA).

What are the market hours to buy TYRA?

You can place orders 24/7. Transactions will be executed when the US market (NYSE/NASDAQ) is open, from 9:30 PM to 4:00 AM WIB. Gotrade also provides access to pre-market and after-hours trading, so you have more flexibility and aren't limited to regular working hours. Market hours may change due to daylight saving time and holidays. In Gotrade, you can see the market status (open/closed) directly in the app.

How do I tell if TYRA is expensive or cheap?

There's no single perfect answer, but common approaches include: Compare valuation (e.g., P/E, P/S) against historical averages or competitors. Review revenue and earnings growth. Check margins and cash flow. Evaluate business outlook and the company's position within its industry. You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

Tyra Biosciences, Inc. Common Stock (TYRA) Stock Price: Oct 12 Close $19.60

Latest news

Investors Business Daily

Tyra Plummets To 10-Month Low On Mixed Bladder Cancer Results

NegativeTYRASeptember 9, 2026

Investors Business DailyNegative

Tyra Plummets To 10-Month Low On Mixed Bladder Cancer Results

TYRA

Stocktwits

TYRA Stock Heads For Best Day In Nearly 10 Months — Sets Date For Key Phase 2 Bladder Cancer Drug Readout

TYRASeptember 4, 2026

Stocktwits

TYRA Stock Heads For Best Day In Nearly 10 Months — Sets Date For Key Phase 2 Bladder Cancer Drug Readout

TYRA

The Motley Fool

This Biotech Stock Has Surged 250% in a Year as One Investor Discloses $10 Million New Position

TYRAMarch 20, 2026

The Motley Fool

This Biotech Stock Has Surged 250% in a Year as One Investor Discloses $10 Million New Position

TYRA

The Motley Fool

News tone: automated (AI) classification of the article's content, not a price prediction.

About Tyra Biosciences, Inc. Common Stock

No description available.

SectorHealthcare

IndustryBiotechnology

Employees87

CEODr. Todd Harris Ph.D.

IPO DateSep 13, 2021

HeadquartersCarlsbad, CA

Key Executives

Name	Title	Year Born
Dr. Todd Harris Ph.D.	Co-Founder, CEO, President & Director	1979
Mr. Bhavesh Ashar M.B.A.	Chief Operating Officer	1969
Dr. Douglas Warner M.D.	Chief Medical Officer	1972
Mr. Daniel Bensen	Co-Founder & Chief Discovery Officer	1975
Mr. Alan Fuhrman CPA	Chief Financial Officer	1957
Ms. Julia Rueb	VP of Finance & Principal Accounting Officer	1986
Dr. Robert L. Hudkins Ph.D.	Chief Technology Officer	1955
Dr. Ronald V. Swanson Ph.D.	Chief Scientific Officer	1963
Mr. Ali D. Fawaz J.D.	General Counsel & Secretary	—
Ms. Sarah Honig	Senior VP of Corporate Development & Strategy	—

Fundamentals

Valuation

Market cap$1.35B

Price-to-book value3.36

Price-earnings ratio-8.00

Return on Equity-46.00%

Return on Assets-43.00%

Earnings Per Share

Earnings Per Share$-2.39

Income Statement

Average volume1,017,206

EBITDA$-148.03M

1 year high (52w)$40.65

1 year low (52w)$13.35

Dividend

Dividend amount$0.00

Dividend yield0.00%

Source: third-party data provider, as of October 13, 2026

Technical indicators

RSI 14: 33.67
MACD 12/26/9: -1.51
EMA 9 of MACD: -1.37
MACD histogram: -0.13
SMA 50: $24.53; Price below SMA 50
EMA 50: $24.36; Price below EMA 50
SMA 200: $30.39; Price below SMA 200
EMA 200: $27.00; Price below EMA 200

Calculated by Gotrade from daily closing prices, as of October 12, 2026. Technical data, not a recommendation.

Analyst views

3 analyst ratings

Third-party analyst opinion, not a recommendation from Gotrade.

Analyst consensus:Buy

100% Buy

0% Hold

0% Sell

Analyst price target

Low: $29.00
Average: $40.67
High: $53.00

Wedbush

Robert Driscoll

Buy

Target price

$53.00

HC Wainwright & Co.

Mitchell S. Kapoor

Buy

Target price

$29.00

Oppenheimer

Mazahir Alimohamed

Buy

Target price

$40.00

Seasonality

Monthly price change (%)

	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
2021										+37.6	+9.1	-33.0
2022	-7.0	-12.5	-3.7	-33.2	-18.7	+13.3	+27.1	-33.2	+28.9	-12.0	-0.7	+9.4
2023	+50.2	+0.1	+25.8	-11.4	+2.0	+23.8	-3.5	+5.8	-8.2	-11.4	-1.3	+19.3
2024	-4.6	+53.7	-17.7	+1.3	-11.3	-0.9	+28.2	+5.8	+9.7	-27.0	-4.3	-12.4
2025	+0.2	-15.5	-17.0	+18.1	-13.2	-0.3	+12.4	+22.2	+11.7	+18.0	+46.2	+26.3
2026	+15.0	+7.4	+17.8	-9.2	-1.9	+5.1	+8.4	-21.9	-13.6	-6.7

Compare stocks

TYRA

Buy TYRA

Market cap

$1.35B

-

Price / Earnings ratio

-8.00

-

Price / Sales ratio

-

Dividend yield

0.00%

-

Average volume

1,017,206

-

Earnings per share

$-2.39

-

Tyra Biosciences, Inc. Common Stock (TYRA) Stock

Fundamentals

Compare with TYRA

Recent news

Tyra Plummets To 10-Month Low On Mixed Bladder Cancer Results

Tyra Plummets To 10-Month Low On Mixed Bladder Cancer Results

TYRA Stock Heads For Best Day In Nearly 10 Months — Sets Date For Key Phase 2 Bladder Cancer Drug Readout

TYRA Stock Heads For Best Day In Nearly 10 Months — Sets Date For Key Phase 2 Bladder Cancer Drug Readout

This Biotech Stock Has Surged 250% in a Year as One Investor Discloses $10 Million New Position

This Biotech Stock Has Surged 250% in a Year as One Investor Discloses $10 Million New Position

Tyra Biosciences Director Sells 247,000 Shares for $5 Million After 38% Rally

Tyra Biosciences Director Sells 247,000 Shares for $5 Million After 38% Rally

Technical indicators

Analyst ratings

Financials

Performance

Debt & Balance Sheet

Revenue to Profit

Earnings

Latest news

Tyra Plummets To 10-Month Low On Mixed Bladder Cancer Results

Tyra Plummets To 10-Month Low On Mixed Bladder Cancer Results

TYRA Stock Heads For Best Day In Nearly 10 Months — Sets Date For Key Phase 2 Bladder Cancer Drug Readout

TYRA Stock Heads For Best Day In Nearly 10 Months — Sets Date For Key Phase 2 Bladder Cancer Drug Readout

This Biotech Stock Has Surged 250% in a Year as One Investor Discloses $10 Million New Position

This Biotech Stock Has Surged 250% in a Year as One Investor Discloses $10 Million New Position

Tyra Biosciences Director Sells 247,000 Shares for $5 Million After 38% Rally

Tyra Biosciences Director Sells 247,000 Shares for $5 Million After 38% Rally

Post-Election Insider Buying in These 6 Stocks Is Huge

Post-Election Insider Buying in These 6 Stocks Is Huge

About Tyra Biosciences, Inc. Common Stock

Key Executives

Fundamentals

Valuation

Earnings Per Share

Income Statement

Dividend

Technical indicators

Analyst views

Seasonality

Compare stocks

Market cap

Price / Earnings ratio

Price / Sales ratio

Dividend yield

Average volume

Earnings per share

Stocks in the same sector

FAQ

Trading Lebih Cepat. Lebih Mudah. Lebih Cerdas.

#ReadyGoTrade